Amy Biasella
About Amy Biasella
Amy Biasella is a Senior Analytics Engineer with extensive experience in data mining and analysis, currently working at Arbor Biotechnologies and previously at the Broad Institute. She holds a Graduate Professional Certificate in Computer Programming from Harvard Extension School and a Bachelor of Science in Biochemistry and Molecular Biology from Framingham State University.
Work at Arbor Biotechnologies
Amy Biasella has been serving as a Principal Research Associate at Arbor Biotechnologies since 2021. In this role, she focuses on data mining, visualization, and analysis for next-generation sequencing (NGS) library and sequencing teams. Her work contributes to the advancement of biotechnological research and development in Cambridge, Massachusetts.
Work at Broad Institute
Since 2014, Amy Biasella has held the position of Senior Analytics Engineer at the Broad Institute in Cambridge, Massachusetts. Her responsibilities include operational analytics and visualization, utilizing tools such as Tableau. She has played a significant role in automating COVID-19 sample processing in a Biosafety Level 2 (BL2+) environment, supporting diagnostic efforts during the pandemic.
Education and Expertise
Amy Biasella earned a Graduate Professional Certificate in Computer Programming (Java) from Harvard Extension School, completing her studies from 2017 to 2019. She also holds a Bachelor of Science (B.S.) in Biochemistry and Molecular Biology from Framingham State University, where she studied from 2003 to 2007. Her educational background supports her expertise in operational analytics and visualization.
Background in Process Development
Before her current roles, Amy Biasella worked at the Broad Institute as a Process Development Associate I - III from 2007 to 2014. During this time, she gained extensive experience in Illumina sequencing process development, which laid the foundation for her current work in analytics and NGS.
Future Interests
Amy Biasella has expressed a future interest in returning to bench work, with a focus on next-generation sequencing development, protein engineering, and assay development. This indicates her ongoing commitment to advancing her skills and contributing to the field of biotechnology.